Benelux unquote
NPM acquires Iddink from Nordian
Deal reported to be worth around €100m
Gimv appoints new board director
De Scheemaecker succeeds Van den Driessche, who resigned earlier this year
PMV invests in Bubble Post
Company to expand internationally in 2015
Benelux healthcare funds and exits prosper while dealflow dips
VC healthcare investments in Benelux have dipped but fund closes and exits abound
JC Flowers’ Fidea sold to Anbang
Firm acquired Fidea in October 2011 from KBC
Waterland's Keylane buys Artena
Keylane's Actuera brand has wholly acquired the business
Qbic et al. invest €2m in Biogazelle
Company claims to have experienced 70% annual growth rate
PPM Oost, Zeeuws invest $5.2m in Mimetas
Company span out from University of Leiden in the Netherlands
NPM’s Vanderlande bolts on Smatec
Vanderlande has been in NPM's portfolio since 1988
Apax makes Exact offer
Offer gives Exact market cap of €730m
Aztec opens Dutch office
New Amsterdam base is firm's fourth onshore office
Pulsar Network Capital launches €75m Sustainable Food Fund
GP also announces appointment of two new partners
LSP raises €80m for LSP 5 fund
Fund received commitment from large pharma company
Forbion holds first close for FCF III
Fund has a target of €150-200m
Antea buys Uniekaas from Parcom
Antea takes 25% stake in the company
Gimv sells Trustteam to Naxicap
Naxicap will support the company in entering French market
Notion leads $2.4m round for Wercker
Company recently opened San Francisco office
Écart Invest sells BVA to Bencis
Bencis to form new group through merger of two Dutch auction houses
Accel et al. invest €10m in Catawiki
Deal marks Accel's first investment in the Netherlands
Ballast Nedam completes asset sale with Bencis, calls off H2 deal
Bencis has created European Clean Fuel Company from Ballast assets
Deal in focus: Enterprise makes 12x money on AVG exit
AVG's market cap increased under Enterprise's ownership by 11.5x
Aglaia launches Oncology Fund II
Fund focuses exclusively on biotechs developing anti-cancer therapies
VC-backed ProQR raises $97.5m in IPO
Listed Dutch biotech develops drugs designed for the treatment of genetic disorders
NPM hires new investment manager
Van Niekerk on Dutch government start-up foundation New Venture